Keyword: Federal Trade Commission


Six States Join FTC Lawsuit to Block Amgen-Horizon

27.06.2023 -

Six US states – New York, California, Illinois, Wisconsin, Minnesota and Washington – have joined the Federal Trade Commission's lawsuit to block Amgen's proposed nearly...


US FTC Wants Court to Hold “Pharma Bro” in Contempt

31.01.2023 -

The Federal Trade Commission (FTC) has asked a US federal judge to hold “pharma bro” Martin Shkreli in contempt for forming another drug company that it said violates a...


FTC Blocks Evonik Takeover of Peroxychem

05.08.2019 - The US Federal Trade Commission (FTC) is seeking to block Germany-based Evonik’s acquisition of US rival Peroxychem from One Equity Partners, saying that it would lead to higher...


Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

23.03.2013 - The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...


Watson Gets US Approval to Buy Actavis

16.10.2012 - Watson Pharmaceuticals has won U.S. antitrust approval to buy Swiss peer Actavis on the condition that it sell a number of their current and future products to two other companies...


FTC Takes "Pay for Delay" Drug Case to U.S. Supreme Court

05.10.2012 - The Federal Trade Commission asked the US Supreme Court on Thursday to take up its fight against deals between brand-name drug companies and generic firms which they say delay the...


U.S. Finds No Wrongdoing in Yasmin Patent Settlement

02.10.2012 - U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...


US FTC Loses Bid to Block Pay-for-delay Drug Deals

26.04.2012 - The Federal Trade Commission on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-name drug companies make with...